Home » Topics » Briefs » Other news to note

Other news to note
RSS

Progress in CNS drug development at Daiichi

Sep. 13, 1996

Chugai's CNS pipeline

Sep. 13, 1996

CNS research at Toyama

Sep. 13, 1996

ImmunoTherapeutics name change

Sep. 13, 1996

Stryker acquires Osteo

Sep. 13, 1996

Proposed acquisition agreement between Genzyme and Neozyme II

Sep. 13, 1996

Daiichi's diagnostics pipeline

Sep. 13, 1996

Chugai's metabolic drug R&D pipeline

Sep. 13, 1996

Daiichi's anticancer drugs in development

Sep. 13, 1996

Chugai's anticancer R&D pipeline

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.